Sarah Cannon Research Institute
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Sarah Cannon Research Institute
Sep 10, 2024, 13:42 |
Blog
Vivek Subbiah: A morning walk to support melanoma research
Vivek Subbiah posted on X by himself adding: "Amazing day for a morning walk to…
Sep 9, 2024, 15:30 |
Societies
25 Posts Not To Miss from Day 2 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization committed…
Sep 9, 2024, 13:41 |
Dialogues
Dr. Vivek Subbiah on Pioneering Precision Oncology and Global Clinical Trials | OncoInfluencers #13
Dr. Vivek Subbiah, Chief of Early Phase Drug Development at Sarah Cannon Research Institute, joins…
Sep 1, 2024, 17:03 |
Blog
Vivek Subbiah: Our WHY is YOU!
Vivek Subbiah shared a post on LinkedIn: ''Clinical trials, Drug development unit dream team. Yes!…
Sep 1, 2024, 16:26 |
Blog
Vivek Subbiah: Clinical trial vs fiction
Vivek Subbiah shared an article on LinkedIn: ''Every single drug, medicine, and treatment you’ve ever…
Aug 31, 2024, 09:08 |
Insight
Vivek Subbiah: Our commentary on Precision oncology across the ages
Vivek Subbiah shared on LinkedIn about a recent paper titled "Precision oncology across the ages:…
Aug 29, 2024, 15:47 |
Insight
Navneet Majhail: Advances and practical application of precision medicine in oncology
Navneet Majhail shared a post on LinkedIn: "On Sarah Cannon Cancer Network grand rounds today,…
Aug 26, 2024, 10:00 |
Insight
Vivek Subbiah: We need to challenge Standard-of-care Paradigms in the Precision Oncology era
Vivek Subbiah shared a post on LinkedIn: "Such a delight to deliver a lecture and join…
Aug 25, 2024, 13:09 |
Blog
Allison Zibelli and Erika Hamilton discussing data from the DESTINY-Breast06 and A-BRAVE trials
Sidney Kimmel Comprehensive Cancer Center at Jefferson shared a post on LinkedIn: "Dr. Allison Zibelli,…
Aug 16, 2024, 14:58 |
Blog
Ishwaria Subbiah about fighting burnout on Healthcare Unfiltered with Chadi Nabhan
Chadi Nabhan, Chief Medical Officer and Head of Strategy of Ryght, shared on X: "Can…
Aug 15, 2024, 14:41 |
Insight
Vivek Subbiah: Transforming the fragmented silos of medicine into a wheel of collaboration
Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared a post by…
Aug 15, 2024, 13:34 |
Blog
Navneet Majhail: New complex blood cancer, HCT, and cellular therapy program at HCA Florida Healthcare North Florida
Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon Research Institute, shared a post on…
Aug 14, 2024, 07:07 |
Insight
Vivek Subbiah: The evolving landscape of tissue-agnostic therapies in precision oncology
Vivek Subbiah shared on X: "Such a delight to share with in Open Access for…
Aug 14, 2024, 06:17 |
Insight
Sumanta K. Pal: Viable solutions to "fragmentation" in medicine
Sumanta K. Pal shared a post by Vivek Subbiah on X: "Wonderful piece in Nature…
Aug 10, 2024, 13:38 |
Insight
Vivek Subbiah: Fragmentation in medicine harms patients and hinders research
Vivek Subbiah shared on LinkedIn: "Just published in Nature Medicine: Fragmentation in medicine harms patients…
Aug 6, 2024, 16:22 |
Blog
Student Early Exposure - program for students about the possibilities within the field of clinical research, writes Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Attention Students Looking for Professional Development…
Aug 5, 2024, 16:40 |
Insight
Shaalan Beg: Modernizing evidence generation for regulatory approvals at ASCOBT24
Shaalan Beg, Senior Advisor for Clinical Research at the National Cancer Institute, shared a post…
Aug 4, 2024, 11:27 |
Blog
Vivek Subbiah: You're all going for gold
Vivek Subbiah shared a post on LinkedIn: "Thrilled to see all our staff in the…
Aug 3, 2024, 11:42 |
Blog
Ishwaria Subbiah: Privileged to present at the July 1 Rounds of the FDA Oncology Center of Excellence
Ishwaria Subbiah shared a post on LinkedIn: "That's a wrap! July 2024 took me to…
Aug 1, 2024, 15:05 |
Blog
Learn about opportunities to join - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Our team members are deeply committed to…
Jul 27, 2024, 22:17 |
Insight
Commentary led by Marleen Kok highlights all questions in early TNBC post-KN522
Erika Hamilton shared on X: "This commentary led by Marleen Kok highlights all the pertinent…
Jul 19, 2024, 22:55 |
Blog
Potential of "smart warheads" in oncology - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Exciting developments in cancer treatment! Erika…
Jul 19, 2024, 08:35 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Erika Hamilton
As our next oncoinfluencer we are excited to feature Dr. Erika Hamilton, a prominent medical…
Jul 13, 2024, 12:13 |
Insight
Vivek Subbiah: Great JAMA weekend read on highlights from ASCO24
Vivek Subbiah shared on LinkedIn: "Happy Friday, World! Hot off the press - published in…
Jul 12, 2024, 19:08 |
Insight
Interesting study - A meta-analysis of nonrelapse mortality after CAR T cell therapy
Vivek Subbiah shared on X: "Interesting study published in NatureMedicine: A systematic review and meta-analysis…
Jul 12, 2024, 11:08 |
Blog
Vivek Subbiah: How to Spend Way Less Time on Email Every Day
Vivek Subbiah shared a post on X: "How to Spend Way Less Time on Email…
Jul 5, 2024, 02:47 |
Drugs
A new standard for treating limited-stage small cell lung cancer - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Dr. David R. Spigel recently shared research on durvalumab…
Jul 2, 2024, 05:00 |
Insight
AlphaFold’s recent advancements and its potential impact on predictive medicine
AI in Precision Oncology shared a post on X: "AIPO is excited to publish a…
Jul 1, 2024, 16:19 |
Insight
Vivek Subbiah: Two back to back futuristic papers in the journal AI In Precision Oncology
Vivek Subbiah shared on LinkedIn: “Thrilled to have the opportunity to mentor some of the…
Jul 1, 2024, 15:15 |
Blog
Cesar Perez: Increasing the Impact of Immunotherapy
Cesar Perez, Director of Drug Development at Lake Nona DDU of Florida Cancer Specialists and…
Jul 1, 2024, 14:03 |
Drugs
Robert Jotte presents how Adagrasib shows improvement in PFS and ORR in previously treated patients - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Significant advancements in NSCLC treatment! SCRI's Dr. Robert Jotte…
Jul 1, 2024, 02:25 |
Blog
Insights from ESMOGI24 by Cathy Eng
ESMO GI 2024 took place from June 26 to 29 in Munich, Germany, featuring both…
Jun 29, 2024, 10:28 |
Blog
David R. Spigel's presentation at the 2024 ASCO on crucial developments in lung cancer treatment - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: “David R. Spigel, presentation at the…
Jun 29, 2024, 09:05 |
Blog
Erika Hamilton: Always worth major celebration when we see survival improve by 10 months in metastatic cancer
Erika Hamilton shared a post by Healthbook on LinkedIn, adding: "Always worth major celebration when we…
Jun 28, 2024, 06:15 |
Blog
The American Journal of Managed Care highlights the latest research from Erika Hamilton
Sarah Cannon Research Institute shared the following post on LinkedIn: “AJMC - The American Journal…
Jun 26, 2024, 02:20 |
Insight
Brigatinib in NF2-Related Schwannomatosis
Vivek Subbiah shared on X: “Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors. NF2-related schwannomatosis (NF2-SWN,…
Jun 25, 2024, 04:14 |
Blog
Dr. Meredith McKean's recent discussion on PD-1–refractory advanced melanoma at ecancer - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Dr. Meredith McKean's recent discussion on PD-1–refractory advanced melanoma…
Jun 24, 2024, 17:19 |
Blog
David R. Spigel commented on the major lung cancer research updates for Patient Power
Sarah Cannon Research Institute shared on LinkedIn: .…
Jun 24, 2024, 15:19 |
Insight
Vivek Subbiah: Precision therapy with ALK inhibitor in ALCL
Vivek Subbiah shared on X: . "Precision therapy with anaplastic lymphoma…
Jun 24, 2024, 13:33 |
Blog
Erika Hamilton's insights into the future of ADCs in oncology - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared the following post on LinkedIn: “We are thrilled to share…
Jun 22, 2024, 15:13 |
Drugs
Vivek Subbiah: Another FDA approval to adagrasib plus cetuximab for KRAS G12C-mutated colorectal cancer
Vivek Subbiah shared on LinkedIn: "It's Friday and time for another FDA approval! FDA grants…
Jun 16, 2024, 05:49 |
Drugs
Vivek Subbiah: Another Tissue-Agnostic FDA approval
Vivek Subbiah shared on LinkedIn: . "Yes!…
Jun 15, 2024, 14:10 |
Drugs
Vivek Subbiah: FDA granted full traditional approval of RET inhibitor Selpercatinib in RET+ thyroid cancers
Vivek Subbiah shared on LinkedIn: . "FDA granted full traditional…
Jun 10, 2024, 15:27 |
Blog
Cathy Eng: Join us on 6/22/2024 for ASCO24 post meeting update
Cathy Eng shared on X/Twitter: "Please join us in at Nashville 6/22/2024! For those that didn't…
Jun 10, 2024, 10:16 |
Societies
It is humbling to present trials that advance care for patients to our colleagues from across the world - SCRI Oncology Partners
SCRI Oncology Partners recently shared on LinkedIn: "SCRI Oncology Partners and Sarah Cannon Research Institute…
Jun 10, 2024, 10:08 |
Societies
Vivek Subbiah: I endorse Dr. Giuseppe Curigliano for ESMO President 2027-28
Vivek Subbiah shared on X: "The elections for the ESMO President 2027-2028 are happening, its…
Jun 7, 2024, 09:11 |
Insight
Erika Hamilton: Happy to share the publication in Annals of Oncology
Erika Hamilton shared a post on X: “Happy to share the publication in Annals of…
Jun 7, 2024, 00:29 |
Societies
Erika Hamilton: I am leaving ASCO24 filled with renewed energy and inspiration
Erika Hamilton shared a post on LinkedIn: "ASCO24 did not disappoint! So appreciative of Lynn…
Jun 5, 2024, 04:25 |
Blog
Giuseppe Curigliano: Excited to see NBC News highlight the groundbreaking results of DESTINY-06
Giuseppe Curigliano reposted Erika Hamilton's post on LinkedIn, adding: . "Excited to see NBC…
Jun 4, 2024, 16:28 |
Societies
Erika Hamilton: Data that pCR translates to outcome in TNBC
Erika Hamilton shared a post on X: “PEARLY: Adriamycin Cyclophosphamide (AC) to Taxane versus AC…
Jun 3, 2024, 15:25 |
Societies
15 Posts From ASCO24 Day 3 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
Jun 2, 2024, 08:53 |
Blog
Erika Hamilton: Lynn Schuchter emphasizes how important communication is in oncology care
Erika Hamilton shared on LinkedIn: "ASCO president Lynn Schuchter emphasizes how important communication is in…
Jun 1, 2024, 23:04 |
Societies
Vivek Subbiah: Come chat with us at the Sarah Cannon Research Institute booth
Vivek Subbiah shared on LinkedIn: "If you are at ASCO24, come say hi! Meet and…
Jun 1, 2024, 15:03 |
Positive
Vivek Subbiah: This recognition is incredibly humbling and I am beyond grateful
Vivek Subbiah, recently posted on LinkedIn: "This recognition is incredibly humbling and I am beyond…
May 31, 2024, 09:57 |
Career
Devon Dickey Womack: Jason Hammonds is stepping into a new role as McKesson’s Chief Operating Officer, Oncology and Specialty
Devon Dickey Womack, President of The US Oncology Network, shared on LinkedIn: "The healthcare industry…
May 29, 2024, 22:44 |
Blog
Vivek Subbiah: Prepping to ASCO24 - Super Bowl for oncology
Vivek Subbiah shared on LinkedIn: "Countdown to ASCO24 Annual meeting is on! Excited for the biggest cancer…
May 26, 2024, 06:54 |
Positive
Yvonne Award Winners 2024 by OncoDaily
We are excited to announce the esteemed winners of the Yvonne Award 2024 by OncoDaily, designed…
May 25, 2024, 09:42 |
Societies
SCRI Oncology Partners introduces its members
Sarah Cannon Research Centre (SCRI) Oncology Partners shared on LinkedIn: With our new LinkedIn page, we…
May 25, 2024, 08:27 |
Blog
Vivek Subbiah: Thank you to the OncoDaily team for the esteemed 'Voice of Oncology Award' at ASCO 2024
Vivek Subbiah shared a post by OncoDaily on LinkedIn, adding: "Gratitude overload! Sending a heartfelt…
May 24, 2024, 00:42 |
Societies
Vivek Subbiah wholeheartedly supports and endorses Dr. Giuseppe Curigliano for ESMO President 2027-28
Vivek Subbiah shared on X: "Exciting news! The elections for the ESMO President 2027-2028 are…
May 22, 2024, 08:29 |
Blog
Vivek Subbiah: Let's celebrate the power of research and the hope
Vivek Subbiah shared on LinkedIn: "On this Clinical Trials Day, I’m immensely grateful for the incredible…
May 19, 2024, 14:11 |
Societies
20 Posts Not To Miss From ESMOBreast24!
ESMO Breast Cancer 2024 (ESMOBreast24) took place as an onsite and online event in Berlin,…
May 17, 2024, 14:50 |
Insight
Erika Hamilton: Rupert Bartsch delivers a sobering reminder on brain metastasis
Erika Hamilton shared a post on X: “Rupert Bartsch delivers a sobering reminder: Although we can…
May 16, 2024, 10:07 |
Blog
Melissa Johnson: Thrilled to help launch SCRI Oncology Partners’ LinkedIn page!
Melissa Johnson, Director of Lung Cancer Research at Sarah Cannon, shared a post by SCRI…
May 16, 2024, 10:02 |
Blog
Updated Breast Cancer Screening Recommendation - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Updated Breast Cancer Screening Recommendation. SCRI breast cancer…
May 13, 2024, 12:27 |
Insight
Vivek Subbiah: Interpreting and integrating genomic tests results in clinical cancer care
Vivek Subbiah shared on X: "Published now in the May/ June issue 2024 at CA:…
May 13, 2024, 07:59 |
Blog
Erika Hamilton: Check out our new practice LinkedIn page
Erika Hamilton shared a post by SCRI Oncology Partners on LinkedIn, adding: ''Check out our new practice…
May 9, 2024, 11:35 |
Insight
Vivek Subbiah: SERENA-1 monotherapy results in Annals of Oncology
Quoting Vivek Subbiah on X: . "A Phase 1 dose escalation and expansion trial of…
May 9, 2024, 11:00 |
Insight
Vivek Subbiah: AlphaFold 3 is beyond amazing!
Vivek Subbiah shared on X: “Wow! Just when we thought Alphafold 1,2 are groundbreaking, it’s…
May 8, 2024, 10:41 |
Blog
Erika Hamilton: An update from the previous 2016 guideline and a couple highlights
Erika Hamilton shared a post on LinkedIn: "Thanks to News Nation and Nichole Berlie for having…
May 6, 2024, 08:10 |
Blog
Vivek Subbiah: A goosebumps moment
Vivek Subbiah shared on X/Twitter: "A goosebumps moment and an example of what an amazing…
May 5, 2024, 00:31 |
Blog
Erika Hamilton: Thanks for having me on USPTF updated breast screening recommendations
Erika Hamilton shared on LinkedIn: “Thanks to News Nation and Nichole Berlie for having me…
May 2, 2024, 14:25 |
Insight
Fabrice Andre: A nice seminar around Precision Medicine
Vivek Subbiah shared a post by Fabrice Andre, Head of Research Division at Gustave Roussy…
May 2, 2024, 02:08 |
Blog
Variant allele frequency by Vivek Subbiah
Vivek Subbiah shared on X: "Variant allele frequency: a decision-making tool in precision oncology? Trends…
Apr 30, 2024, 05:44 |
Blog
Ishwaria Subbiah: FTC Announces Rule Banning Non-competes
Ishwaria Subbiah shared a post on X: "Wow. FTC (Federal Trade Commission) Announces Rule Banning…
Apr 29, 2024, 20:00 |
Opinion
Erika Hamilton: Really feel like we don't need to be testing for HER-2 for TDXd in breast cancer
Erika Hamilton shared a post by Giuseppe Curigliano, Chief of the Clinical Division of Early…
Apr 26, 2024, 12:00 |
Blog
Vivek Subbiah: Window of opportunity (WOO) studies across cancer subtypes by Barbara Pistilli
Vivek Subbiah shared a post on X/Twitter: "Window of opportunity (WOO) studies across cancer subtypes?…
Apr 26, 2024, 11:10 |
Blog
Vivek Subbiah: The world of oncology converges in Zurich, Switzerland!
Vivek Subbiah posted on X/Twitter: ''The world of oncology converges in Zurich, Switzerland! Such an…
Apr 26, 2024, 09:41 |
Blog
Vivek Subbiah: Read a recap of 'AI at the Interface' at AACR24 plenary session in AACR Annual Meeting News
Vivek Subbiah posted on X/Twitter: ''Yes! The future IS now! 'AI at the Interface: Accelerating…
Apr 25, 2024, 20:18 |
Positive
Vivek Subbiah: HUGE MILESTONE in all of medicine and a huge win for patients and families with sickle cell disease and β-Thalassemia
Quoting Vivek Subbiah's post on X/Twitter: "Hot off the press! HUGE MILESTONE in all of…
Apr 24, 2024, 12:07 |
Blog
Vivek Subbiah: One mission = Eradicate cancer
Vivek Subbiah shared on Twitter/X: "One of the greatest advantages of in person scientific meetings is…
Apr 23, 2024, 16:35 |
Blog
Stephanie Graff: Sheila Johnson is a force—I hope to carry her energy and spirit in all that I do
Stephanie Graff shared a post by Erika Hamilton on X and added: "Sheila Johnson is…
Apr 23, 2024, 12:12 |
Societies
Vivek Subbiah: Fantastic overview of Molecular Tumor Boards - MTB 101 and in-depth thought-provoking lecture by the amazing Ben Westphalen
Vivek Subbiah shared a post on X: "Fantastic overview of Molecular Tumor Boards - MTB…
Apr 23, 2024, 11:34 |
Blog
Vivek Subbiah: What a beautiful venue for a terrific meeting - the Italian Summit of Precision Oncology
Vivek Subbiah shared a post on X: "American Academy of Rome! What a beautiful venue…
Apr 23, 2024, 11:10 |
Blog
Ishwaria Subbiah: Whether it's access to clinical trials or palliative care, cancer challenges are global, and so are our collaborations!
Ishwaria Subbiah recently shared on LinkedIn: "To Brazil from New Orleans in just a weekend!…
Apr 20, 2024, 05:32 |
Blog
Navneet Majhail: Congratulations to the EBMT for 50 years of supporting international transplant and cellular therapy community
Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon Research Institute, shared on X: "Congratulations…
Apr 19, 2024, 20:37 |
Societies
Vivek Subbiah: 4th ESMO webinar of the Precision Oncology series
Vivek Subbiah shared a post by Diogo Martins Branco, Board Member at AICSO, on X/Twitter,…
Apr 15, 2024, 21:22 |
Blog
Michelyn Smith: Let's spread awareness about clinical trials
Michelyn Smith, Head of Talent Acquisition at Sarah Cannon Research Institute, shared a post by Vivek…
Apr 14, 2024, 22:37 |
Insight
Vivek Subbiah: Prostate cancer cases are projected to double to 2.9 million per year by 2040
Quoting Vivek Subbiah's post on X/Twitter: "Prostate cancer cases are projected to double to 2.9…
Apr 14, 2024, 12:08 |
Blog
Vivek Subbiah: Talk about shaking the field of cancer research- cracking KRAS
Vivek Subbiah shared a post on LinkedIn: ''Talk about shaking the field of cancer research- cracking…
Apr 14, 2024, 03:32 |
Career
Vivek Subbiah: Sending massive congratulations to the incredible Patricia M. LoRusso for her Presidency at the American Association for Cancer Research!
Vivek Subbiah shared a post on X/Twitter: "Sending massive congratulations to the incredible AACR President,…
Apr 14, 2024, 03:08 |
Societies
Vivek Subbiah: The future of cancer research shines brightly!
Quoting Vivek Subbiah on X/Twitter: "The future of cancer research shines brightly! It was an honor…
Apr 14, 2024, 02:26 |
Insight
Vivek Subbiah: A pan-cancer analysis of the microbiome in metastatic cancer
Quoting Vivek Subbiah on X/Twitter: "A pan-cancer analysis of the microbiome in metastatic cancer: Cell.…
Apr 12, 2024, 16:21 |
Societies
Vivek Subbiah: Where does the AACR24 Plenary Chair work with the ASCO Plenary Chair?
Vivek Subbiah shared a post on LinkedIn: "Where does the American Association for Cancer Research AACR24 Plenary…
Apr 11, 2024, 06:54 |
Blog
Vivek Subbiah: Watching the celestial event at the AACR24 brings everyone together
Vivek Subbiah shared a post on X: "Wow! Watching the celestial event at the AACR24 brings…
Apr 10, 2024, 09:21 |
Blog
Vivek Subbiah: Future of cancer research is bright!
Vivek Subbiah shared on X/Twitter: "Future of cancer research is bright! So nice to see…
Apr 10, 2024, 09:09 |
Blog
Vivek Subbiah: Super delighted to meet the amazing Elizabeth McKenna, Executive Editor of Cancer Discovery
Vivek Subbiah shared on X/Twitter: "Super delighted to meet the amazing Elizabeth McKenna, Executive Editor…
Apr 10, 2024, 06:07 |
Blog
Vivek Subbiah: Such a delight to meet with the terrific Arul Chinnayan at AACR24
Vivek Subbiah recently shared on his X/Twitter: ''Such a delight to meet with the terrific…
Apr 9, 2024, 16:59 |
Positive
Erika Hamilton: This is the power of clinical trials!
Erika Hamilton shared a post by Mel Mann, a Patient Advocate for Oncology, Health Equity,…
Apr 9, 2024, 13:58 |
Blog
Vivek Subbiah: Profiling tumor ecosystems in native tissue context
Vivek Subbiah recently shared on his X/Twitter: ''Profiling tumor ecosystems in native tissue context: Michael…
1
2
All:
164
Posts:
1 - 100
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube